The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.

DUI

D017323 MeSH Prohlížeč

CUI

M0026307

CAS

21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-

Předchozí užití

Hematoporphyrins (1985-1992)

Historická pozn.

93; was DIHEMATOPORPHYRIN ETHER (NM) 1985-92

Online pozn.

use DIHEMATOPORPHYRIN ETHER (NM) to search DIHEMATOPORPHYRIN ETHER 1985-92

Veřejná pozn.

93; DIHEMATOPORPHYRIN ETHER was indexed under HEMATOPORPHYRINS 1985-92